You are here

antibodies

Lilly scores $210M supply deal for newly authorized coronavirus antibody cocktail

Fierce Pharma

Sun, 02/28/21 - 11:56 pm

government contract

Fledgling CDMO Lakes BioScience blueprints $490M antibody factory at ex-GlaxoSmithKline site

Fierce Pharma

Wed, 02/24/21 - 11:18 pm

Lake BioScience

drug manufacturing

Eyeing variants, Adagio starts phase 1 trial of COVID-19 antibody

Fierce Biotech

Tue, 02/16/21 - 11:16 am

Adagio Therapeutics

clinical trials

On the hunt for a better antibody, BigHat Biosciences debuts with $19M Series A to scale its 'wet lab' AI platform

Endpoints

Wed, 02/10/21 - 10:26 am

BigHat Biosciences

artificial intelligence

machine learning

drug development

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

Fierce Pharma

Wed, 02/10/21 - 10:16 am

Emergency Use Authorization

Bristol Myers makes late play for COVID-19 antibody space, picking up 2 early-phase molecules from Rockefeller

Fierce Biotech

Wed, 02/3/21 - 10:56 am

Bristol-Myers Squibb

Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly's does not - study

Reuters

Wed, 01/27/21 - 08:06 pm

Regeneron says monoclonal antibodies prevent Covid-19 in study

Stat

Tue, 01/26/21 - 11:34 am

Lilly antibody combo slashed COVID-19 deaths, hospitalizations in high-risk patients

Fierce Pharma

Tue, 01/26/21 - 11:29 am

US to pay up to $2.6B for more doses of Regeneron's COVID-19 antibody drug

BioPharma Dive

Wed, 01/13/21 - 11:34 pm

government contracts

Celltrion's COVID-19 antibody improves outcomes in phase 2

Fierce Biotech

Wed, 01/13/21 - 10:48 am

clinical trials

Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive results

Marketwatch

Wed, 12/30/20 - 10:42 am

GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients

Endpoints

Thu, 12/17/20 - 06:25 pm

Vir Biotechnology

clinical trials

Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren't they getting to more patients?

Fierce Pharma

Thu, 12/17/20 - 06:19 pm

AbbVie pulls the trigger on a Covid-19 antibody, going all in on a drug discovered by research alliance

Endpoints

Mon, 12/14/20 - 11:04 pm

Gottlieb op-ed: Manufacturers need to ramp up production of antibodies as 'Covid insurance policy'

Endpoints

Mon, 12/14/20 - 11:01 am

AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation

Fierce Biotech

Mon, 12/7/20 - 10:37 am

Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19

Pharmaceutical Business Review

Thu, 12/3/20 - 10:51 am

government contract

Regeneron, UPenn to use gene therapy tools to deliver a COVID-19 antibody drug

BioPharma Dive

Tue, 12/1/20 - 11:32 pm

Twist Bioscience's COVID-19 'nanobodies,' inspired by llamas, show promise in hamsters

Fierce Biotech

Tue, 11/24/20 - 10:36 am

Twist Biosciences

animal studiens

Pages